Related Experiment Videos

[Glycosylated hemoglobin (HbA1)--an index in the control of diabetes]

Vutreshni Bolesti
|January 1, 1987
PubMed

Insights

This study shows that Hemoglobin A1c (HbA1c) levels correlate with blood sugar control in type 2 diabetes patients. HbA1c and glycemia are complementary for monitoring diabetes management and lipid disorders.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Clinical Chemistry

Background:

  • Type 2 diabetes mellitus (T2DM) management requires continuous monitoring of glycemic control and associated complications.
  • Glycemic variability and lipid metabolism are critical factors in T2DM progression and cardiovascular risk.

Purpose of the Study:

  • To investigate the correlation between serum Hemoglobin A1c (HbA1c) levels and glycemic parameters in T2DM patients.
  • To evaluate HbA1c as a potential marker for lipid disorders in individuals with T2DM.

Main Methods:

  • Study included 108 patients (68 males, 40 females) with T2DM of varying duration.
  • Analysis of serum HbA1c levels in relation to fasting blood glucose, 24-hour glycemic fluctuations, and carbohydrate metabolism decompensation.
  • Assessment of HbA1c as a marker for high-density lipoprotein (HDL) cholesterol, triglycerides, and total cholesterol.

Main Results:

  • A significant positive correlation was found between serum HbA1c and fasting blood glucose levels.
  • Elevated HbA1c correlated with increased glycemic variability and poorer carbohydrate metabolism control.
  • Serum HbA1c demonstrated a positive association with HDL cholesterol synthesis and, to a lesser extent, with triglycerides and total cholesterol levels.

Conclusions:

  • Glycemia and HbA1c are not interchangeable but provide complementary information for effective diabetes mellitus (DM) follow-up care.
  • HbA1c serves as a valuable marker for assessing glycemic control and can indicate the status of lipid disorders, including HDL cholesterol synthesis, in T2DM patients.

Related Concept Videos